Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Iridex ( (IRIX) ) has shared an update.
On March 9, 2026, IRIDEX Corporation signed a triple net lease with SFIII Hellyer entities to relocate its corporate headquarters to 5215 Hellyer Avenue in San Jose, California, securing approximately 30,784 square feet of office space. The lease is expected to commence on July 1, 2026, or earlier upon occupancy, positioning the company in a larger, modern facility that could support future operational needs.
The initial lease term runs for 90 months, with an option to extend for an additional 60 months at the greater of the prior rent or prevailing market rent, giving IRIDEX long-term real estate flexibility. Annual minimum rent will be about $646,464 in the first full year and $665,857 in the second, with 3% annual increases thereafter, while a six-month rent abatement and responsibility for operating expenses, taxes, and utilities reflect a standard cost structure for a triple net headquarters lease.
The most recent analyst rating on (IRIX) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on Iridex stock, see the IRIX Stock Forecast page.
Spark’s Take on IRIX Stock
According to Spark, TipRanks’ AI Analyst, IRIX is a Neutral.
The score is held down primarily by weak financial performance (multi-year revenue decline, ongoing losses, sharply reduced equity, and negative cash flows). Technicals are supportive but appear overbought, adding near-term risk. The latest earnings call is a relative positive with improving revenue, cost discipline, and guidance toward cash-flow positivity, but it has not yet outweighed the underlying balance sheet and cash flow concerns.
To see Spark’s full report on IRIX stock, click here.
More about Iridex
IRIDEX Corporation operates in the medical technology sector, focusing on ophthalmic laser systems and related products used to treat eye diseases. The company serves eye care professionals and clinics, with a market focus on vision preservation and minimally invasive ophthalmic procedures in both domestic and international markets.
Average Trading Volume: 88,494
Technical Sentiment Signal: Hold
Current Market Cap: $22.86M
Find detailed analytics on IRIX stock on TipRanks’ Stock Analysis page.